CTOs on the Move

PHC Holdings

www.phchd.com

 
This is the website of PHC Holdings Corporation, which is a global innovator in healthcare solutions.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.phchd.com
  • 1300 Michael Drive, Suite A
    Wood Dale, IL USA 60191
  • Phone: 800.858.8442

Executives

Name Title Contact Details
Roman Schaal
Global Head of Information Security Profile

Similar Companies

Attune Pharmaceuticals

Attune Pharmaceuticals is a private biotechnology company focused on discovering and developing novel orally-administered small-molecule therapeutics for the treatment of rare diseases.

Biopure Corporation

Biopure Corporation is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arjo

We believe that empowering movement within healthcare environments is essential to quality care. ⚖️ https://t.co/e11hfbUA49

Ostrove Associates

Ostrove Associates is a Elizabeth, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tanner Pharma

For over 18 years, Tanner Pharma Group has provided highly specialized pharmaceutical services to its partners around the world. Leading pharmaceutical and biotech companies partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes, and source comparator drugs for clinical trials and bioanalysis. By partnering with Tanner Pharma, manufacturers are able to focus on their primary markets and strategies while ensuring that the services they need will follow a strictly controlled protocol of quality. Headquartered in the U.S. with offices in London, São Paulo and Mexico City, Tanner Pharma Group`s reach includes Europe, Asia, the Middle East, Australia, Canada and Latin America. We measure our value as a company based on the lives we help to improve. For all of us involved in the pharmaceutical supply chain - manufacturers, distributors, pharmacists, doctors, and others - it is ultimately the patient that matters most. Therefore, we start each day with a renewed commitment to ethically supply unlicensed medicines to markets where access continues being a challenge.